Radioligand cancer therapy forces manufacturers to race the clock

$ 21.50

4.8 (307) In stock

Radioligand therapy is a 'game -hanger' for cancer treatment, but it forces manufacturers to race against a ticking clock.
Radioligand therapy is a 'game -hanger' for cancer treatment, but it forces manufacturers to race against a ticking clock.

Recent advances and futuristic potentials of nano-tailored doxorubicin for prostate cancer therapy - ScienceDirect

Advanced Prostate Cancer: AUA/SUO Guideline - American Urological Association

MU Research Reactor (@MURRMatters) / X

Unveiling Potential: Exploring Alpha Emitter Radiopharmaceuticals - Xtalks

From molecular mechanisms of prostate cancer to translational applications: based on multi-omics fusion analysis and intelligent medicine

MU Research Reactor (@MURRMatters) / X

Debiopharm (@DebiopharmNews) / X

mCRPC Treatment

Cancer-fighting nuclear medicine firms find home in central Indiana – Indianapolis Business Journal

Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities

PDF) Peptide Drug Conjugates and Their Role in Cancer Therapy

News NorthStar Medical Radioisotopes, LLC

Fresh from the biotech pipeline: fewer approvals, but biologics gain share

Health system readiness for radioligand therapy - The Health Policy Partnership